Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7336 p165-171
12 February 2005

This section
Reprint   Photocopy

PDF 390K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

165 Bids open for pharmacy chlamydia screening pilot Community pharmacists are being asked to submit bids to pilot services to make chlamydia screening available throughout London and Cornwall, Public Health Minister Melanie Johnson announced this week ...more

165 Pharmacists to be recruited to new study tackling alcohol misuse Pharmacists in Glasgow are to be recruited to a new study that will examine how feasible it is for community pharmacists to provide structured interventions to people who drink too much alcohol ...more

165 Scotland consults pharmacists on better use of skill mix How to make better use of skill mix in pharmacy is the subject of a consultation published this week by the Scottish Executive ...more

166 Part two of renal NSF focuses on chronic disease The second part of the National Service Framework for Renal Services, which focuses on chronic kidney disease, has been published by the Department of Health ...more

166 Co-op promotes Valentine’s organ donation Co-op Pharmacy is encouraging its customers to think about organ donation by giving away specially designed organ donor Valentine’s cards ...more

166 SSRIs should be used with caution during pregnancy Selective serotonin reuptake inhibitors should be used with caution in pregnancy because of the risk of neonatal convulsions and neonatal withdrawal syndrome ...more

166 Pharmacists advised of atomoxetine risk Potential liver problems associated with the use of atomoxetine (Strattera) have been brought to the attention of pharmacists and doctors by the Committee on Safety of Medicines ...more

166 No mortality benefit for PPIs Use of proton pump inhibitors by patients with bleeding ulcers does not have a significant effect on mortality. However, they reduce episodes of further bleeding and the need for surgery ...more

166 St John’s wort versus paroxetine St John’s wort has been shown to be as effective as paroxetine in patients suffering from moderate to severe depression and has also been shown to be better tolerated ...more

167 Society devolution group proposes English board Separate boards for England, Scotland and Wales, which will provide strategic leadership and support for pharmacy practice development relevant to each home country, have been proposed by the Royal Pharmaceutical Society’s Devolution Review Group ...more

167 Agreement reached on Charter action costs The Save Our Society campaign (SOS) has reached agreement with the Royal Pharmaceutical Society on the costs it has to pay following last year’s court action over the new Charter ...more

167 First primary care records held on national database A GP practice has become the first in England to take a significant step towards developing the shared electronic patient care record ...more

167 East Anglian Pharmaceuticals The Office of Fair Trading has decided to allow Phoenix Healthcare Distribution Ltd to purchase the independent pharmaceutical wholesaler East Anglian Pharmaceuticals ...more

168 Judge orders dentist to be struck off A dentist was ordered to be struck from the dental register with immediate effect last week by a High Court judge ...more

168 Shipman case pharmacist faces Statutory Committee The pharmacist criticised during the Shipman Inquiry for not noticing abnormal prescribing that allowed Shipman to collect diamorphine which he then used to kill many patients, will appear before the Royal Pharmaceutical Society’s Statutory Committee on 21 and 22 February ...more

168 Extra stage of clinical trials is under consideration The Government is considering introducing a fourth stage in the vetting of medicines before granting marketing approval ...more

168 Medicines regulation and sponsorship in one department is best for balance, says minister Medicines regulation and advocacy of the pharmaceutical industry are within the same Government department because it is the best way of getting the right balance between the two, according to Parliamentary Under-Secretary of State for Health Lord Warner ...more

168 MHRA to improve its image The Medicines and Healthcare products Regulatory Agency has appointed a director of communications ...more

168 Child medicine licensing plans inadequate Proposals to encourage the licensing of medicines for children fail to meet their needs and will encourage paediatric use of risky and useless medicines, according to an association of European consumer organisations ...more

169 Scheme cuts co-proxamol prescribing rates at PCT A scheme developed by Mansfield District Primary Care Trust in Nottinghamshire has led to an 80 per cent reduction in co-proxamol prescribing rates and could be adopted by other primary care organisations to facilitate the withdrawal of co-proxamol announced last week ...more

169 Diamorphine supplies remain low NHS supplies of diamorphine will remain low until the end of March, the Department of Health confirmed this week ...more

169 Almost a third of cancer patients use complementary and alternative medicines Health care professionals need to be aware that many cancer patients are using complementary and alternative medicines (CAMs) and they should help educate patients about these therapies ...more

169 Paracetamol should be preferred OTC analgesic Paracetamol remains a better option than non-steroidal anti-inflammatory drugs (NSAIDs) for most patients requiring an over-the-counter analgesic ...more

170 Pharmaceutical regulations to be reviewed by Cabinet Office this year Legislation affecting pharmacies and pharmaceutical manufacturers is to be reviewed this year by the Cabinet Office Regulatory Impact Unit ...more

170 Call to increase use of drug-eluting stents Cardiologists are lobbying the Department of Health and calling for a doubling of the number of angioplasties they can carry out with drug-eluting stents ...more

170 Mumps cases rise in England and Wales Nearly 5,000 cases of mumps were notified to the Health Protection Agency for the first four weeks of 2005, compared with 358 during the same period in 2004 ...more


R&D news

171 Use radioimmunotherapy earlier for lymphomas Radioimmunotherapy should not be reserved for chemotherapy-resistant lymphomas, but should be initiated early in the course of the disease ...more

171 DNA vaccine prevents TB recurrence Reactivation of dormant tuberculosis bacteria can be prevented by combining drug treatment with a DNA vaccine, new research suggests ...more

171 Ximelagatran as effective as warfarin but not cost effective The anti-clotting drug ximelagatran (Exanta) may be as effective as warfarin for the treatment of deep vein thrombosis and the prevention of stroke in patients with atrial fibrillation, but it is unlikely to be cost effective ...more

171 New technique to overcome antiviral drug resistance Antiviral drug resistance could be eliminated by the development of therapies targeting host signalling pathways instead of the virus itself ...more

171 Viagra improves cardiac function Sildenafil (Viagra) could be used to treat hypertrophic heart disease ...more

171 Cell-cultured smallpox vaccine Researchers from Kentucky have designed a cell-cultured smallpox vaccine that has been shown to be a safe alternative to calf-lymph derived vaccine, which is no longer acceptable because of the risk of bovine spongiform encephalitis ...more

171 Nicotine exacerbates Alzheimer’s Chronic nicotine administration may increase the brain abnormalities that occur in Alzheimer’s disease ...more

171 New drug beats Glivec resistance Scientists have developed a compound, called ONO12380, that may overcome the problem of imatinib (Glivec) resistance in patients with chronic myelogenous leukaemias ...more

Back to Top


©The Pharmaceutical Journal